How To Improve Patient Care With Genomic Information

Studies conducted by Waleed Alabsi show that there has been an extraordinary leap in the knowledge of the human genome and its role in health and disease in recent years. It requires computational technologies to make sense of

Studies conducted by Waleed Alabsi show that there has been an extraordinary leap in the knowledge of the human genome and its role in health and disease in recent years. It requires computational technologies to make sense of genomic data. There have been advances in technology that have enabled an ever-increasing capacity for correct diagnosis of diseases and the development of effective and targeted treatment strategies. Genomic information also provides opportunities to assess predispositions to disease prompting a more focused clinical monitoring.

Let us have a look at how genomic information is being used to improve patient care:


Qatar Genome System is being used in the refining of diagnosis and guiding therapeutic approaches to cancer. Genomic information assists clinicians in determining treatment strategies through the classification of tumors according to their mutations and corresponding drug sensitivities. In most cases where genomic information is used, patients have been spared complex and costly procedures like bone marrow transplants. In other situations, the use of genomic information stabilizes the patient’s cancer development.

Genomic information is also being utilized to refine cancer diagnosis and prognosis improving the patient’s quality of life. Genomic information provides an analysis of the circulating DNA in the plasma of patients enabling non-invasive tumor detection and the monitoring of responses improving patient management.

Drug prescription and development:

According to Waleed Alabsi, the use of genomic information enables a healthcare provider to predict accurately how a patient will respond to drugs. This enables the doctor to provide the appropriate prescription of medication.

Qatar Genome is being used to suggest new therapeutic applications for existing drugs with a significant reduction in costs and to select individuals for clinical trials

Diagnosing and characterizing genetic disease:

Genomic information improves patient care through the search for variants implicated in undiagnosed genetic diseases with the use of this information guiding treatment of patients.

Genome sequencing is being used to assess genetic contributions to complex diseases where there are multiple gene variants involved in disease development and progression.

Enables personalized genetic healthcare:

Waleed Alabsi shows that genetic information can be integrated with other clinical and environmental data which clinicians and patients query the sequence to accurately prescribe treatments determine the susceptibility of the disease and identify drug sensitivities. This enables the healthcare provider to determine the best course of action to manage, monitor, and ameliorate risk or prevent the disease.

Integrating genomic and clinical information:

Qatar Genome provides a pathway from patient DNA sequencing to a clinical treatment plan through the integration of the patient’s information with knowledge databases that contain known genotype-phenotype correlations.

Practitioners and Qatar Genome System work as a team to assess the genomic variants identified through the use of genomic sequencing arriving at an effective treatment plan. Challenges that occur when integrating genomic and clinical data necessitate an investment in bioinformatics.

Storing and sharing population data:

According to Waleed Alabsi, Genomic information of an individual’s genomic sequencing can be correlated with a larger population. Through the analysis of these large datasets, it will enable the uncovering of patterns and relationships that would otherwise not be evident.

The use of genomic information and linking it with the larger population datasets would add significant value to the current healthcare system through the acceleration of individualized genomic medicine. Data mining will allow for evidence-based planning of the healthcare needs of a population by the government.

Waleed Alabsi recommends that a government can add significant value to its healthcare system by adding genomic information and linking large population datasets to a controlled system through the acceleration of personalized genomic medicine.

Genomic medicine refers to the study of genes and how they interact with our health. It investigates how a person’s biological information can improve their clinical care outcomes.

Genomic medicine refers to the study of genes and how they interact with our health. It investigates how a person’s biological information can improve their clinical care outcomes.

Genomics differs from genetics in that it refers to someone’s entire genetic makeup. It dwells into how they relate and react with each other and is associated with conditions with a broader range of triggers such as heart disease diabetes cancer and asthma. The Qatar Genome System launches a huge database through which drugs are prescribed to enhance the health care system. Waleed Alabsi has played an irreplaceable role in the launch of this Genome project.

How does Waleed Alabsi Group use genomics in medicine?

  1. Provides conclusive diagnosis especially in cases where the cause of a wide range of symptoms cannot be pinpointed.
  2. It helps conduct prenatal tests either to screen the baby or where there is already family history to help parents make informed choices and plans. In cases where there is a family history of serious genetic disorders, genomics helps prospective parents whether or not they are carriers and if they can pass it on to their children. It can also predict whether someone is likely to develop the inherited condition later in life.
  3. Someone’s genetic structure can show whether they are susceptible to suffer certain diseases like stroke heart disease and cancer. Factors such as high cholesterol levels can be detected too.
  4. Each patient can have treatment and medications that are tailored to their needs
  5. The Qatar Genome System helps doctors with diagnosis, treatment, and the spotting of symptoms across a wide cohort of patients.

What can I expect and what is genetic counseling?

The appointment with Waleed Alabsi Group may take some time and you may be required to bring other members of your family. The medical history of your family will be mapped out and explored and it is very much likely that you will have a medical examination too. Having to find out that there could be life-changing or life-limiting conditions to your future is a serious and traumatic experience. Besides counseling, Qatar Genome offers tests with the option of having these done on the day of your visit or later to give you time to think about possible implications.

The results can sometimes take weeks or even months to get depending on the rarity of the genetic abnormality of how easy it is to find. Prenatal tests though will be arrived at sooner.

Aftercare to be provided will be based on the results and the nature of what is being tested for. Some patients will be referred back to their doctors along with full details or they may go on with treatment at a Waleed Alabsi Group. Those that do not show symptoms will be provided with support and advice about lifestyle changes to minimize risk.

The future of Genomic Medicine:

Waleed Alabsi Group is working endlessly towards finding chemical or genetic bottlenecks for conditions that are difficult to diagnose due to the wide variety of genes involved. The ability to switch off a vital reaction along its pathway would aid in diagnosis and treatment.


Qatar Genome looks into epigenetics as an emerging field that takes genomics one step further. It is founded on the concept that each gene has its chemical tag that informs how the gene will act. It is possible to switch off the gene or switch on the gene depending on its chemical tag. These genetic modifications can be passed on to the next generation creating a more variable level to genetic inheritance.

The Waleed Alabsi Group appreciates the fact that lots of disease solutions lie within the genetic makeup. Therefore, they provide cutting-edge solutions through availing medical equipment that utilizes such data to enhance healthcare.

Qatar Genome is the largest project in the Middle East that promotes genome sequencing to the national level for implementing precision medicine.

Qatar Genome introduces huge data based on genome sequencing to enhance personalized treatment. To make Qatar a pioneering country in the implementation of precision medicine, we introduce such a project. The huge data even helps researchers for their further study on different drug responses. Here, you will learn how this project helps the healthcare system and how it is beneficial for the population of Qatar and the world. Mr Waleed Alabsi, the CEO of the Alabsi Group, provides strong support to the Qatar Genome Project.

What is genome sequencing:

Genome sequencing reveals information regarding the order based on the entire genome of an organism. Often genome sequencing is conducted along with the DNA sequencing methods, and the whole details are stored using computer software.

A whole-genome sequence is another popular process where the determination of the DNA sequence in an organism’s genome has been made. Whole-genome sequencing proves to be important for researchers. Besides, the process has a great contribution in identifying the core of personalized medicine. Even the process can reveal essential facts regarding therapeutic interventions.

Remember that genome sequencing and DNA profiling are different. That later deals with the likelihood of an individual or a group from where gene material has come without revealing additional details regarding genetic relationships and specific diseases. Qatar Genome, collaborating with Qatar Biobank, has introduced a project that is based on genome sequencing to improve the personalized medication. It helps the researchers to work on different health-related projects for some breakthrough discoveries.

Qatar Foundation manages the project and plans with the best strategies to implement the needed practices for introducing the database. Based on the seven building blocks, we create the foundation of the project.

  1. We collaborated with Qatar Biobank.
  2. We use local genomic data and bioinformatics infrastructure.
  3. We enhance the nationwide research partnership.
  4. Use local human capacity.
  5. Draft policies and regulations.
  6. Implement genomics into the clinical setting.

Qatar Genome Project is the largest project that promotes genomic research and clinical implementations for prescribing precision medicine. The study includes large-scale genome sequencing and multi-omics data. This huge project needs clear strategies and partnerships at the local and national levels to meet the goals. Using the local human capacities and collaborating with the healthcare organizations, we run awareness campaigns to make everyone aware of our projects and how it helps the health care system.

Qatar Genome is one of the partners of the Alasbi Group, a company led by Mr.Waleed Alabsi, who helps in improving strategies of different businesses for achievements. Please contact us for more details.

Qatar Genome Project makes the health care industry stronger with genomic research that helps identify risks of different diseases. Read on to know more.

Qatar Genome Project works for making the health care system even stronger. Working on precision medicines, the members have gone through a strong research-based phase of analyzing and verifying data regarding genomes. It is mainly a population-based study where locally-researched publications have been incorporated to offer a better view of gene variations, especially those that cause diseases. Mr. Waleed Alabsi supports and promotes Qatar Genome Project to enhance the health care of patients. You can contact us to get more details about the projects.

The project aims to implement precision medicine in Qatar. All national stakeholders have participated in this program. It plans a reference map to identify specific gene variants. This database helps policymakers include genomic data to introduce a better treatment.

Besides, the members also work with local researchers who concentrate on genomic study and research different databases. We bring to people the most comprehensive genomic research that will provide a big help to researchers in this field.

Qatar Foundation:

Qatar Foundation is a non-profit organization offering a valuable contribution to the entire development of Qatar, from the knowledge economy to the carbon economy. The foundation looks after important parameters of society, including education, research, and community development.

The foundation works on planning the knowledge-based skills for offering better skills to the young generation. It develops key solutions based on key sciences. Besides the science and the knowledge skills, the foundation also protects the cultural heritage addressing the social needs of the community.

Who manages the program:

The national QGP committee takes care of everything in the program. The members of the committee belong to the medical, research, and educational group of Qatar. Qatar Biobank has a great contribution in making a complete database on precision medicine.

The QGP provides a national platform where stakeholders can exchange information and make maximum use of resources for a better health care system in Qatar.

Genomic operation division:

The genomic operation division is one of the strong pillars of the Qatar Genome Project (QGP). Using clinical bio-informatics statistics, the members plan the best things for data analysis and clinical genome-wide sequencing data. The division develops commonly used, an open-source, bioinformatics software application for filtering information.

Genomic data for healthcare:

Genomic data includes clinical, pharmaceutical data, and lifestyle information that help you determine early signs of disease or reveal the individual risk of developing the disease. The data proves to be very helpful for identifying the underlying causes of diseases, making the treatment more personalized and effective.

But, the information is useful and needs regular updates to improve the outcome. It helps physicians to offer more precise treatment at the point of care. Qatar Genome Project will introduce Qatar as a pioneering country in implementing precision medicine. Waleed Alabsi, the CEO of the Alabsi Group, has been supporting the project and encourages health care industries to adopt it for improving the approaches to patients.

Other Medical Services